These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38325402)

  • 1. Diabetes and Fatty Liver.
    Stefan N; Roden M
    Exp Clin Endocrinol Diabetes; 2024 Mar; 132(3):136-141. PubMed ID: 38325402
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes and Fatty Liver.
    Stefan N; Roden M
    Exp Clin Endocrinol Diabetes; 2022 Sep; 130(S 01):S113-S116. PubMed ID: 35373310
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatty liver: yet another silent killer.
    Javed M
    J Ayub Med Coll Abbottabad; 2014; 26(1):1-2. PubMed ID: 25358204
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe asymptomatic non-alcoholic fatty liver disease in routine diabetes care; a multi-disciplinary team approach to diagnosis and management.
    Armstrong MJ; Hazlehurst JM; Parker R; Koushiappi E; Mann J; Khan S; Philips A; Chandler L; Johnson J; Round M; Haydon G; Karamat MA; Newsome PN; Tomlinson JW
    QJM; 2014 Jan; 107(1):33-41. PubMed ID: 24131545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.
    Clemente MG; Mandato C; Poeta M; Vajro P
    World J Gastroenterol; 2016 Sep; 22(36):8078-93. PubMed ID: 27688650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Weight loss can cure fatty liver].
    Füeßl HS
    MMW Fortschr Med; 2015 Sep; 157(16):38. PubMed ID: 26783621
    [No Abstract]   [Full Text] [Related]  

  • 7. Histological features of non-alcoholic fatty liver disease: what is important?
    Hashimoto E; Tokushige K; Farrell GC
    J Gastroenterol Hepatol; 2012 Jan; 27(1):5-7. PubMed ID: 22188024
    [No Abstract]   [Full Text] [Related]  

  • 8. [Consensus on integrative medical diagnosis and treatment of non-alcoholic fatty liver disease].
    ;
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Feb; 31(2):155-8. PubMed ID: 21425564
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease and diabetes.
    Reyes-García R; Rozas-Moreno P; Llamoza-Torres CJ; Mezquita-Raya P
    Med Clin (Barc); 2017 Jan; 148(1):33-38. PubMed ID: 27751514
    [No Abstract]   [Full Text] [Related]  

  • 10. [Non-alcoholic fatty liver disease].
    Wójcik K; Piekarska A
    Pol Arch Med Wewn; 2006 Feb; 115(2):172-81. PubMed ID: 17274475
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment. Topics: I. Pathophysiology, diagnosis and treatment; 1. Nonalcoholic fatty liver disease].
    Takamura T
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):836-44. PubMed ID: 23772495
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply: To PMID 25865049.
    Vilar-Gomez E; Friedman SL; Romero-Gomez M
    Gastroenterology; 2015 Dec; 149(7):1988-9. PubMed ID: 26515488
    [No Abstract]   [Full Text] [Related]  

  • 13. [2nd prize in the competition of works in hepatology GSSR 2010 new approaches to treatment of patients with Nash type 2 diabetes].
    V'iuchnova ES; Babina SM
    Eksp Klin Gastroenterol; 2011; (8):91-6. PubMed ID: 22629763
    [No Abstract]   [Full Text] [Related]  

  • 14. Editors' Introduction to the NAFLD and NASH Special Issue.
    Fuchs M; Schnabl B
    Dig Dis Sci; 2016 May; 61(5):1211-3. PubMed ID: 27068170
    [No Abstract]   [Full Text] [Related]  

  • 15. Case report: nonalcoholic steatohepatitis in a teenage girl with type 2 diabetes.
    Nadeau K; Klingensmith G; Sokol RJ
    Curr Opin Pediatr; 2003 Feb; 15(1):127-31. PubMed ID: 12544284
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?
    Firneisz G
    World J Gastroenterol; 2014 Jul; 20(27):9072-89. PubMed ID: 25083080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: Non-alcoholic fatty liver disease.
    Alba LM; Lindor K
    Aliment Pharmacol Ther; 2003 Apr; 17(8):977-86. PubMed ID: 12694079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease and type 2 diabetes mellitus: the hidden epidemic.
    Ismail MH
    Am J Med Sci; 2011 Jun; 341(6):485-92. PubMed ID: 21412139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing non-alcoholic fatty liver disease in diabetes: Challenges and opportunities.
    Lee CH; Lam KS
    J Diabetes Investig; 2017 Mar; 8(2):131-133. PubMed ID: 27181498
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effectiveness of the spa and health resort-based treatment with the application of Essentuki-type drinking mineral waters for the management of non-alcoholic fatty liver disease in the patients presenting with type 2 diabetes mellitus].
    Efimenko NV; Kaĭsinova AS; Fedorova TE; Botvineva LA
    Vopr Kurortol Fizioter Lech Fiz Kult; 2015; 92(3):14-17. PubMed ID: 26285328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.